Harnessing Viral DNA to Combat Cancer: A New Frontier
Written on
Chapter 1 Understanding Our Genome
The majority of our cells house our genetic material—the blueprint for human life. This genetic material, predominantly located in the cell nucleus, also includes fragments of DNA within mitochondria, which are vital for energy production.
Our genome consists of a lengthy sequence of four DNA bases—A, C, G, and T. The segments of DNA that code for proteins are termed genes. These genes are transcribed into messenger RNA (mRNA), which is then translated into amino acid chains that fold into functional proteins. These proteins serve numerous roles within our body.
In addition to these coding genes, there are transcription factors that regulate the activity of other genes. However, it’s important to note that our genes represent only a small fraction of our genome—approximately 2%, based on various estimates.
For years, the vast non-coding regions of our genome were dismissed as "junk DNA." This label, however, is misleading. Non-coding DNA plays crucial roles, particularly in the regulation of protein-coding genes. This portion of our genome also houses remnants of obsolete genes, long repetitive sequences, and viral leftovers known as endogenous retroviruses (ERVs).
Similar to how viruses invade our microbiome, they can insert fragments of their DNA into our genetic makeup. Interestingly, these remnants are not merely inactive; some are linked to diseases such as multiple sclerosis, type 1 diabetes, arthritis, lupus, psoriasis, schizophrenia, and even cancer.
But could these viral remnants also have beneficial roles?
Section 1.1 The Role of p53
Returning to our protein-coding genes, one gene that has garnered significant attention is p53, often referred to as the tumor suppressor gene or the "guardian of the genome."
The protein produced by this gene, p53, plays several critical roles. It is essential for maintaining genetic stability, activating DNA repair processes, preventing unchecked cell division, and initiating cell death if the damage is irreparable. Essentially, it acts as a safeguard against cancerous growths.
Recent research has unveiled another fascinating capability of p53 within cancer cells: it can trigger the expression of ERV sequences. This viral RNA prompts cancer cells to reveal themselves to the immune system.
In their study, researchers experimented with various human cancer cell lines, enhancing p53 activity. In contrast to normal cells, where p53 inhibits ERV activity, the augmented p53 in cancer cells led to increased ERV expression.
With this activation, ERVs began replicating themselves, producing double-stranded RNA, which signals a viral infection. As a result, the cancer cells behave as if they are under viral attack, attracting immune system killer cells with interferons.
Instead of dodging immune detection, these cancer cells essentially wave a red flag.
Ancient viruses in human DNA could help fight cancer - YouTube
This video discusses how ancient viral remnants in our DNA can be leveraged to enhance cancer treatment strategies, focusing on the role of p53 in immune activation.
Section 1.2 Evidence from Melanoma Patients
The findings were corroborated through biopsies from melanoma patients. When a dual MDM2/MDMX inhibitor (which elevates p53 levels) was applied to these samples, it activated ERVs, leading to the release of interferon signals and the influx of tumor-fighting T cells.
Furthermore, when combined with immune therapy in mice with melanoma, this treatment resulted in a remarkable 75% reduction in tumor size.
Overall, the research highlights that ERV expression is a pivotal mechanism through which p53 activation helps overcome tumor immune evasion, transforming the tumor microenvironment into a more favorable state. This provides a strong rationale for the combined use of MDM2 inhibitors and immunotherapy.
However, further refinement is necessary to optimize therapeutic applications regarding dosage, frequency of administration, and potential drug interactions.
In summary, the contributions of these viral remnants may offer promising avenues for cancer treatment, showcasing the unexpected benefits of our genetic history.
Can Viruses Help Treat Cancer? - YouTube
This video explores the potential of utilizing viral DNA remnants in the treatment of cancer, emphasizing the significance of p53 in immune system engagement.